Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours

NCT04375904 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT04375904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04375904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours
Lead sponsor
Cancer Trials Ireland
Phase
Phase 2
Overall status
Recruiting
Start date
December 22, 2020
Completion date
February 29, 2032
Enrollment
68 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc/oligometastatic cancer (single lung lesion)